APREZO 20 TAB

About

APREZO 20 TAB is an oral immunomodulatory agent, likely containing apremilast, used in the treatment of psoriatic arthritis and moderate to severe plaque psoriasis. It works by selectively inhibiting phosphodiesterase 4 (PDE4), an enzyme that regulates inflammatory mediators. By reducing the activity of PDE4, it decreases the production of pro-inflammatory cytokines and increases anti-inflammatory mediators, thereby modulating the immune response.

This mechanism helps to reduce inflammation, alleviate joint pain and swelling in psoriatic arthritis, and improve skin lesions in psoriasis. APREZO 20 TAB offers a systemic treatment option for patients who have not responded to or cannot tolerate other therapies, providing a targeted approach to managing chronic inflammatory conditions and improving overall disease burden.

Uses

• Treatment of active psoriatic arthritis.
• Management of moderate to severe plaque psoriasis.
• Reducing joint pain and swelling.
• Improving skin lesions and scaling.

Directions For Use

Take one tablet orally, usually twice daily, as directed by your physician. Follow the prescribed titration schedule.

Benefits

• Reduces inflammation in psoriatic arthritis.
• Improves skin clearance in psoriasis.
• Oral administration, avoiding injections.
• Targeted immunomodulatory action.
• Can be used as monotherapy or with other DMARDs.
• Generally well-tolerated with manageable side effects.

Side Effects

• Diarrhea
• Nausea
• Upper respiratory tract infection
• Headache
• Abdominal pain
• Vomiting
• Weight loss
• Depression (rare, monitor mood changes)
• Insomnia
• Fatigue
• Migraine
• Nasopharyngitis

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake may exacerbate gastrointestinal side effects.
• Pregnancy - Not recommended during pregnancy; use only if potential benefit justifies potential risk to the fetus. Consult a doctor.
• Breastfeeding - It is unknown if it passes into breast milk; breastfeeding is not recommended. Consult a doctor.
• Liver - No dose adjustment is typically needed for mild to moderate liver impairment. Use with caution in severe impairment.
• Kidney - Dose reduction is required for patients with severe kidney impairment; consult a doctor.
• Lung - No specific contraindications related to lung conditions; however, monitor for any new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.